On the heels of reaching an acquisition agreement that brings Ipsen a commercialized follicular lymphoma drug, the Paris-based drugmaker is expanding its reach in cancer through a licensing deal that takes it into a new area of drug research. Ipsen is collaborating with Marengo Therapeutics, a startup with technology that activates T cells and gets … Read more
Each day in the US, about 6,000 women reach menopause. More than 75% of these women experience uncomfortable symptoms like hot flashes, which usually last between seven and nine years. Oftentimes, women feel like there are no treatments for the physical and emotional changes they experience during this life stage, so they opt to silently … Read more
Health insurance company AmeriHealth New Jersey is partnering with Thyme Care, an oncology care management company, to help its members navigate cancer diagnoses. The new alliance starts on Jan. 1, 2023. Thyme Care, based in Nashville and founded in 2020, focuses on assisting patients through their cancer journey by providing education and support on their … Read more
Earlier this year, a patient of an Oklahoma hospital had been in and out of the emergency department six times in the previous 10 days for treatment of a severe bone infection. But because he lacked trust in the healthcare system, he didn’t want to stay in the hospital. So he was offered care in … Read more
As a mother of two young boys, Ellen DaSilva said she and other parents in the US feel “generally feel pretty underserved by the existing pediatric care infrastructure.” She and her husband have waited hours in the emergency room to obtain answers to simple questions about their children’s health, and they sometimes wait days for … Read more
Never before have clinical researchers had more options at their fingertips when designing a study. As technology leaps ahead, companies are sending more notifications, collecting larger amounts of data, and adding more apps, wearables, and ePROs to studies. But researchers need to be considerate about the fact that many potential participants are dealing with burnout, … Read more
A precision medicine is only as good as its target. While targeted therapies now address many types of cancer, tumors still frequently develop mutations that help them escape a drug. One strategy to address tumor escape is combining different cancer drugs. Biotech startup IDRx aims to use scientific knowledge of tumor biology to develop new … Read more
Cardiology has the heart attack, oncology has the fateful diagnosis date, but there is no “kidney attack” to serve as a traumatic wake-up call for those at risk of kidney diseases. There is no event to urgently change someone’s point of view; “From this moment forward, you will pay attention to your kidneys and do … Read more
Even before Covid-19 disrupted the traditional model for clinical trials, researchers were harnessing the power of technology to make trials more accessible and improve data collection. The movement had coalesced under the banner of decentralized clinical trials, or DCTs, which leverage technology and other non-traditional approaches to monitor patients and gather data without limits on … Read more
FDA approval of a new Arcutis Biotherapeutics drug for plaque psoriasis enables the company to roll out a strategy it believes will win over both payers and patients—lower prices. Arcutis set an $825 wholesale price for each tube of its topical drug, roflumilast, which will be marketed under the brand name “Zoryve.” By comparison, Dermavant … Read more